zoledronic acid has been researched along with Hyperthyroid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofbauer, LC; Klaushofer, K; Köhrle, J; Lademann, F; Misof, BM; Ominsky, MS; Rauner, M; Rijntjes, E; Roschger, P; Tsourdi, E | 1 |
| Asha, HS; Cherian, KE; Paul, TV; Rajan, R | 1 |
| Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C | 1 |
1 review(s) available for zoledronic acid and Hyperthyroid
| Article | Year |
|---|---|
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid | 2015 |
2 other study(ies) available for zoledronic acid and Hyperthyroid
| Article | Year |
|---|---|
Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous Hyperthyroidism.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antibodies; Bone Density; Bone Remodeling; Compressive Strength; Diphosphonates; Glycoproteins; Hyperthyroidism; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Osteogenesis; X-Ray Microtomography; Zoledronic Acid | 2017 |
McCune Albright syndrome: an endocrine medley.
Topics: Adenoma; Bone Density Conservation Agents; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Female; Fibrous Dysplasia, Polyostotic; Humans; Hyperthyroidism; Leg; Musculoskeletal Pain; Pituitary Neoplasms; Rare Diseases; Young Adult; Zoledronic Acid | 2019 |